Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study).
Oncotarget
; 9(9): 8253-8262, 2018 Feb 02.
Article
in En
| MEDLINE
| ID: mdl-29492192
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Oncotarget
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: